Skip Navigation
medication-assisted treatment for substance use disorders

Opioid Treatment Program Certification

Overview

Certification is the process by which the SAMHSA/CSAT Division of Pharmacologic Therapies (DPT) determines that an OTP is qualified to provide opioid treatment under 42 CFR Part 8.

To obtain SAMHSA certification OTPs must successfully complete the accreditation process and meet other requirements enumerated in 42 CFR Part 8. A program may apply to SAMHSA for provisional (initial) certification during the time it is working towards accreditation with a SAMHSA-approved accrediting body. Provisional certification is a temporary certification granted for up to one year to a new OTP during which time it must become accredited.

Upon achieving accreditation a provisionally certified OTP may apply to SAMHSA for renewal (full) certification. Once certified, programs must renew certification at least every three years. For an overview of the OTP accreditation and certification processes, view the Opioid Treatment Regulation page.

Programs applying for accreditation or certification must also comply with the applicable statutes and regulations in their states. Contact information for State Opioid Treatment Authorities can be found on the State Opioid Treatment Authority page.

Applying to SAMHSA for Initial or Renewal OTP Certification

Application to SAMHSA for provisional (initial) certification of a new OTP, or renewal certification of an existing OTP, is made using Form SMA-162, Application for Certification to Use Opioid Drugs in Treatment.

Follow the appropriate link below for information on:

Notifying SAMHSA of Program Changes

Existing OTPs must notify SAMHSA within 3 weeks of either of the following program changes:

  • Change of Program Sponsor
  • Change of Medical Director

In addition, existing OTPs must apply to SAMHSA to receive approval for:

  • Relocation
  • Addition of new medical units (satellite clinics or mobile units)

Additional information about notifying SAMHSA of program changes is available on the instruction page.

For More Information

For more information about OTP certification and opening a treatment program

In states beginning in A-FL, contact

  • Mary Lou Ojeda
    Public Health Advisor
    Division of Pharmacologic Therapies
    SAMHSA Center for Substance Abuse Treatment
    mary.ojeda@samhsa.hhs.gov
    Voice: 240.276.2894
    Fax: 240.276.2710

In states beginning in GA-MI, contact

  • Brandon Johnson
    Public Health Advisor
    Division of Pharmacologic Therapies
    SAMHSA Center for Substance Abuse Treatment
    brandon.johnson@samhsa.hhs.gov
    Voice: 240.276.2889
    Fax: 240.238.9459

In states beginning in MN-OH, contact

  • Nichole Washington Smith
    Public Health Advisor
    Division of Pharmacologic Therapies
    SAMHSA Center for Substance Abuse Treatment
    nichole.smith@samhsa.hhs.gov
    Voice: 240.276.2719
    Fax: 240.276.2710

In states beginning in OK-WY, contact

  • Steve Mason
    Public Health Advisor
    Division of Pharmacologic Therapies
    SAMHSA Center for Substance Abuse Treatment
    steve.mason@samhsa.hhs.gov
    Voice: 240.276.2901
    Fax: 240.276.2710

The mailing address for the above listed personnel is:

  • Division of Pharmacologic Therapies
    Center for Substance Abuse Treatment
    SAMHSA
    1 Choke Cherry Rd.
    Rockville, MD 20857
    (Overnight: 20850)

SMA-162 forms can completed in paper form and faxed or mailed to SAMHSA and (where applicable) the State Opioid Treatment Authority.

PDF File*PDF formatted files require that Adobe Acrobat Reader® program.
Follow this link to download this FREE software now from Adobe.
 
Note to users of screen readers and other assistive technologies: Please report your problems
to us at otp-extranet@opioid.samhsa.gov.
link to the Substance Abuse & Mental Health Services Administration division of pharmacologic therapies logo